The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Following the GBS disease outbreak with cases reported in clusters from Sinhgad Road, Nande Village, Kirkitwadi, Dhayari and DSK Vishwa amongst other areas the State government and PMC issued directio ...

Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Susan Collins (Maine) and Lisa Murkowski (Alaska) expressed reservations about the HHS nominee’s record on vaccines.

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...

If approved, Kennedy will control a $1.7 trillion agency that oversees food and hospital inspections, hundreds of health ...

Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two ...